Goody Science and Technology Past Earnings Performance
Past criteria checks 0/6
Goody Science and Technology has been growing earnings at an average annual rate of 7.8%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been declining at an average rate of 13.5% per year.
Key information
7.8%
Earnings growth rate
8.5%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -13.5% |
| Return on equity | -22.4% |
| Net Margin | -12.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Goody Science and Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 851 | -105 | 755 | 33 |
| 30 Jun 24 | 862 | -86 | 134 | 34 |
| 31 Mar 24 | 894 | 82 | 129 | 32 |
| 31 Dec 23 | 933 | 92 | 130 | 31 |
| 30 Sep 23 | 913 | 91 | -480 | 34 |
| 30 Jun 23 | 958 | 77 | 134 | 35 |
| 31 Mar 23 | 1,000 | -126 | 143 | 36 |
| 01 Jan 23 | 1,056 | -133 | 153 | 38 |
| 30 Sep 22 | 1,198 | -604 | 189 | 41 |
| 30 Jun 22 | 1,335 | -608 | 201 | 46 |
| 31 Mar 22 | 1,450 | -576 | 191 | 55 |
| 01 Jan 22 | 1,493 | -583 | 206 | 55 |
| 30 Sep 21 | 1,588 | -284 | 220 | 59 |
| 30 Jun 21 | 1,552 | -275 | 256 | 58 |
| 31 Mar 21 | 1,567 | -239 | 269 | 56 |
| 31 Dec 20 | 1,429 | -249 | 262 | 52 |
| 30 Sep 20 | 1,456 | -27 | 236 | 49 |
| 30 Jun 20 | 1,528 | 12 | 213 | 50 |
| 31 Mar 20 | 1,491 | -1 | 214 | 49 |
| 31 Dec 19 | 1,640 | 11 | 231 | 54 |
| 30 Sep 19 | 1,535 | -129 | 303 | 55 |
| 30 Jun 19 | 1,552 | -150 | 321 | 54 |
| 31 Mar 19 | 1,607 | -120 | 338 | 56 |
| 31 Dec 18 | 1,664 | -116 | 341 | 54 |
| 30 Sep 18 | 1,916 | 112 | 343 | 53 |
| 30 Jun 18 | 2,084 | 119 | 320 | 83 |
| 31 Mar 18 | 2,108 | 113 | 342 | 67 |
| 31 Dec 17 | 2,062 | 114 | 344 | 57 |
| 30 Sep 17 | 1,827 | 45 | 287 | 43 |
| 30 Jun 17 | 1,658 | 38 | 305 | 0 |
| 31 Mar 17 | 1,542 | 33 | 270 | 0 |
| 31 Dec 16 | 1,531 | 40 | 256 | 0 |
| 30 Sep 16 | 1,451 | 14 | 252 | 0 |
| 30 Jun 16 | 1,521 | 16 | 258 | 0 |
| 31 Mar 16 | 1,687 | 11 | 275 | 0 |
| 31 Dec 15 | 1,772 | 25 | 280 | 0 |
| 30 Sep 15 | 1,912 | -11 | 300 | 0 |
| 30 Jun 15 | 1,876 | 0 | 290 | 0 |
| 31 Mar 15 | 1,889 | 19 | 279 | 0 |
| 31 Dec 14 | 1,837 | 28 | 273 | 0 |
| 30 Sep 14 | 1,803 | 81 | 250 | 0 |
| 30 Jun 14 | 1,788 | 85 | 250 | 0 |
| 31 Mar 14 | 1,786 | 96 | 239 | 0 |
| 31 Dec 13 | 1,764 | 92 | 237 | 0 |
Quality Earnings: 002694 is currently unprofitable.
Growing Profit Margin: 002694 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002694 is unprofitable, but has reduced losses over the past 5 years at a rate of 7.8% per year.
Accelerating Growth: Unable to compare 002694's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002694 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.3%).
Return on Equity
High ROE: 002694 has a negative Return on Equity (-22.39%), as it is currently unprofitable.